Historic Clinical Trial External Control Arm Provides Actionable GEN-1 Efficacy Estimate Before a Randomized Trial Randomized controlled trials are considered the golden standard for estimating ...
YONGIN, South Korea, Dec. 9, 2025 /PRNewswire/ -- GC Genome, a leading clinical genomics and liquid biopsy company, announced that its study analyzing cell-free DNA (cfDNA) fragmentation patterns in 1 ...
Background: Epidemiologic studies that aim to estimate a causal effect of an exposure on a particular event of interest may be complicated by the existence of competing events that preclude the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback